NCT04868526 Dietary Intervention to Mitigate Adverse Consequences of Night Work
| NCT ID | NCT04868526 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Brigham and Women's Hospital |
| Condition | Dietary Habits |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2023-03-29 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2023-03-29 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test whether our dietary intervention can prevent or lessen the negative health effects of night shift work in healthy participants. Participants will: * complete 2 inpatient stays * be provided with identical meals * have frequent blood draws * provide urine, saliva, stool and rectal swab samples
Eligibility Criteria
Inclusion Criteria: * 18-45 yr old * BMI 20.0-29.9 * European/Hispanic/African-American ancestry * No acute, chronic or debilitating medical conditions (e.g. metabolic, cardiovascular, respiratory, neurological, cancers, etc.) Exclusion Criteria: * Currently smoking/vaping or 5 or more years of smoking/vaping * History of drug or alcohol dependency * History of psychiatric illness or disorder
Contact & Investigator
Frank Scheer, PhD
PRINCIPAL INVESTIGATOR
Brigham and Women's Hospital
Frequently Asked Questions
Who can join the NCT04868526 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Dietary Habits. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04868526 currently recruiting?
Yes, NCT04868526 is actively recruiting participants. Contact the research team at mmunn@bwh.harvard.edu for enrollment information.
Where is the NCT04868526 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT04868526 clinical trial?
NCT04868526 is sponsored by Brigham and Women's Hospital. The principal investigator is Frank Scheer, PhD at Brigham and Women's Hospital. The trial plans to enroll 24 participants.